InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,626.02
(
0.54%
)
US TECH 100
18,986.40
(
0.30%
)
Dow Jones
41,393.78
(
0.72%
)
Brent Oil
71.83
(
0.00%
)
Bitcoin
59,887.23
(
-0.20%
)
Post# of 30387
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Headache

Send PM Follow Ignore
Followers 1
Posts 313
Boards Moderated 0
Alias Born 06/16/2005

Headache

Re: mysscat post# 4059

Saturday, 06/03/2006 1:19:40 PM

Saturday, June 03, 2006 1:19:40 PM

Post# of 30387
Another somewhat positive point, which I'm not sure has ever been mentioned on this board, is that a general RECAF-based test would not compete directly with more specific tests. Instead, it would drive demand for more specific tests, creating opportunities to partner with the owners of other diagnostic technology, rather than compete with them.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up